Suchbegriffe: OESOPHAGEAL CANCER, . Treffer: 4
Müller, M; Posch, F; Kiem, D; Barth, D; Horvath, L; Stotz, M; Schaberl-Moser, R; Pichler, M; Greil, R; Jost, PJ; Seeber, A; Amann, A; Schlick, K; Gerger, A; Riedl, JM
Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis.
Ther Adv Med Oncol. 2021; 13: 17588359211039930
Doi: 10.1177/17588359211039930
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Huemer, F; Weiss, L; Regitnig, P; Winder, T; Hartmann, B; Thaler, J; Piringer, G; Schmitt, CA; Eisterer, W; Gänzer, H; Wüstner, A; Andel, J; Jagdt, B; Ulmer, H; Greil, R; Wöll, E
Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer-Results from the AGMT GASTRIC-5 Registry.
J Clin Med. 2020; 9(4):
Doi: 10.3390/jcm9040935
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Allum, W; Lordick, F; Alsina, M; Andritsch, E; Ba-Ssalamah, A; Beishon, M; Braga, M; Caballero, C; Carneiro, F; Cassinello, F; Dekker, JW; Delgado-Bolton, R; Haustermans, K; Henning, G; Hutter, B; Lövey, J; Netíková, IŠ; Obermannová, R; Oberst, S; Rostoft, S; Saarto, T; Seufferlein, T; Sheth, S; Wynter-Blyth, V; Costa, A; Naredi, P
ECCO essential requirements for quality cancer care: Oesophageal and gastric cancer.
Crit Rev Oncol Hematol. 2018; 122(5):179-193
Doi: 10.1016/j.critrevonc.2017.12.019
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Adebahr, S; Schimek-Jasch, T; Nestle, U; Brunner, TB
Oesophagus side effects related to the treatment of oesophageal cancer or radiotherapy of other thoracic malignancies.
Best Pract Res Clin Gastroenterol. 2016; 30(4):565-80
Doi: 10.1016/j.bpg.2016.07.003
Web of Science
PubMed
FullText
FullText_MUG